
Natraj Proteins Q4 FY26 Results: PAT Rs 0.8 Cr
Updated: 25 May 2026 • 11:37 am
Posted by:

Natraj Proteins Q4 FY26 results were declared on May 22, 2026. The company reported PAT of Rs 0.8 crore for the quarter ended March 31, 2026, up 153.3% YoY compared to loss of Rs 1.5 crore in Q4 FY25. Revenue from operations was Rs 8 crore, down 63.6% YoY. Results are on a Standalone basis. Natraj Proteins is a Food Processing and Proteins company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
Natraj Proteins Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | Rs 8 crore | Rs 22 crore | -63.6% |
| Net Profit | 0.8 | 1.5 | +153.3% |
| Basis | Standalone | ||
Note: Q4 FY26 profitability returns. PAT Rs 0.8 crore from loss. Revenue Rs 8 crore (-63.6% YoY). Verify from BSE/NSE audited filings before investment decisions.
Natraj Proteins Q4 FY26 Performance Analysis
The Natraj Proteins Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. The strong PAT growth of 153.3% YoY demonstrates significant earnings improvement and operational leverage. Natraj Proteins operates in the Food Processing and Proteins sector, which benefits from India’s GDP growth above 6.5% and domestic demand conditions in FY26.
Revenue of Rs 8 crore was down 63.6% YoY. Revenue moderation reflects near-term demand headwinds in the Food Processing and Proteins market.
Screen the best stocks on the Univest Screener.
Key Factors Driving Natraj Proteins Q4 FY26 Results
Revenue and Business Execution
Revenue of Rs 8 crore in Natraj Proteins Q4 FY26 was down 63.6% YoY. Revenue pressure reflects the near-term business dynamics in the Food Processing and Proteins sector. The January to March quarter is the fiscal year-end quarter, characterised by strong execution cycles and year-end activity.
Profitability and Margin Trends
The Natraj Proteins Q4 FY26 PAT of Rs 0.8 crore up 153.3% YoY. The PAT growth demonstrates improving operational leverage and business fundamentals in the Food Processing and Proteins space.
India Macro Environment Q4 FY26
India’s macro environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capex of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The RBI’s accommodative stance supported credit and demand conditions. The Food Processing and Proteins sector benefited from these structural tailwinds during the quarter.
FY27 Outlook
Following the firm results, management guidance on FY27 revenue growth, margin trajectory, and capital allocation will be key investor watchpoints. Sustaining the strong profitability momentum will be the primary FY27 focus.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on the company
What is Natraj Proteins Q4 FY26 net profit?
Ans. Natraj Proteins Q4 FY26 PAT of Rs 0.8 crore, up 153.3% YoY from loss of Rs 1.5 crore in Q4 FY25. Results declared May 22, 2026, on a Standalone basis. Verify from BSE/NSE audited filings.
What is Natraj Proteins Q4 FY26 revenue?
Ans. Natraj Proteins Q4 FY26 revenue was Rs 8 crore, down 63.6% YoY. Verify complete financials from BSE/NSE.
When were Natraj Proteins Q4 FY26 results declared?
Ans. Natraj Proteins Q4 FY26 results were declared on May 22, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.
Is Natraj Proteins a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Binny Mills Q4 FY26 Results: PAT Rs 3.5 Cr
KSR Footwear Q4 FY26 Results: PAT Rs 2.5 Cr
NFP Sampoorna Foods IPO Listing Today 25 May 2026: Issue Price Rs 55, Subscribed 1.57x, What to Expect at Listing
Fortis Healthcare Q4 FY26 Results: PAT Rs 271 Cr
Euro Panel Products Q4 FY26 Results: PAT Rs 8.52 Cr
Popular this week
Binny Mills Q4 FY26 Results: PAT Rs 3.5 Cr
KSR Footwear Q4 FY26 Results: PAT Rs 2.5 Cr
NFP Sampoorna Foods IPO Listing Today 25 May 2026: Issue Price Rs 55, Subscribed 1.57x, What to Expect at Listing
Fortis Healthcare Q4 FY26 Results: PAT Rs 271 Cr
Euro Panel Products Q4 FY26 Results: PAT Rs 8.52 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





